Screener
Castle Biosciences CSTL Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's shares (diluted)?
- Castle Biosciences (CSTL) reported shares (diluted) of 29.9M in Q1 2026.
- How has Castle Biosciences's shares (diluted) changed year-over-year?
- Castle Biosciences's shares (diluted) increased by 4.5% year-over-year, from 28.6M to 29.9M.
- What is the long-term trend for Castle Biosciences's shares (diluted)?
- Over 4 years (2021 to 2025), Castle Biosciences's shares (diluted) has grown at a 3.7% compound annual growth rate (CAGR), from 100.4M to 116.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Castle Biosciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude